Skip to main content

Advertisement

SpringerLink
Log in

Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Background and aims

MMP-7, a member of the matrix metalloproteinase family, is believed to play a significant role in the growth and proliferation of colon cancer cells. The aim of this study was to evaluate MMP-7 gene expression in comparison with MMP-1, MMP-3, and MMP-13 in patients with resectable rectal and colon cancer by a semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR).

Materials and methods

Biopsy samples of tumor (n=30) and distant normal mucosa (n=30) from 30 patients were obtained intraoperation. Messenger (m)RNA was extracted from all of the tissue samples and reverse transcribed to double-stranded cDNA. Semi-quantitative RT-PCR was performed to study the MMP gene expression in both the tumor and normal mucosal specimens. MMP mRNA values were expressed relative to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) for each sample.

Results

In all 30 cases an increase in MMP-7 mRNA expression was detected in the cancerous tissue (p=0.00004). In 21 out of 30 cases an increase in MMP-13 mRNA (p=0.023) and in 22 out of 30 cases an increase in MMP-3 mRNA (p=0.075) was detected in the cancerous tissue. In contrast, there was no significant change in the MMP-1 expression of normal and cancerous mucosal specimens in either colon or rectal carcinomas. There were no significant differences between rectum and colon carcinomas.

Conclusion

Taking into account our earlier studies, we conclude that most cases of colorectal carcinogenesis are characterized by enhanced expression of MMP-7, -13, -3 and the gelatinases, whereas MMP-1-expression is very inconsistent and not overexpressed in many cases. MMP-7 inhibition as well as inhibition of MMP-13 and MMP-3 may be a useful preventive or therapeutic adjunct in colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Sternlicht MD, Werb Z (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463–516

    Article  CAS  PubMed  Google Scholar 

  2. Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92:827–839

    Article  CAS  PubMed  Google Scholar 

  3. Curran S, Murray GI (2000) Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 36:1621–1630

    CAS  PubMed  Google Scholar 

  4. Itoh Y, Nagase H (2002) Matrix metalloproteinases in cancer. Essays Biochem 38:21–36

    CAS  PubMed  Google Scholar 

  5. Yu AE, Hewitt RE, Connor EW, Stetler-Stevenson WG (1997) Matrix metalloproteinases. Novel targets for directed cancer therapy. Drugs Aging 11:229–244

    CAS  PubMed  Google Scholar 

  6. Nabeshima K, Inoue T, Shimao Y, Sameshima T (2002) Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol Int 52:255–264

    Article  CAS  PubMed  Google Scholar 

  7. Gearing AJ, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL, Leber TM, Mangan M, Miller K, Nayee P, Owen K, Patel S, Thomas W, Wells G, Wood LM, Woolley K (1994) Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 370:555–557

    CAS  PubMed  Google Scholar 

  8. Overall CM, McQuibban GA, Clark-Lewis I (2002) Discovery of chemokine substrates for matrix metalloproteinases by exosite scanning: a new tool for degradomics. Biol Chem 383:1059–1066

    CAS  PubMed  Google Scholar 

  9. Van den Steen PE, Proost P, Grillet B, Brand DD, Kang AH, Van Damme J, Opdenakker G (2002) Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis. FASEB J 16:379–389

    Article  PubMed  Google Scholar 

  10. Roeb E, Behrmann I, Grötzinger J, Breuer B, Matern S (2000) A MMP-9 mutant without gelatinolytic activity as a novel TIMP-1-antagonist. FASEB J 14:1671–1673

    CAS  PubMed  Google Scholar 

  11. Roeb E, Schleinkofer K, Kernebeck T, Poetsch S, Behrmann I, Jansen B, Matern S, Grötzinger J (2002) The MMP-9 hemopexin domain is a novel gelatin binding domain and acts as an antagonist. J Biol Chem 277:50326–50332

    Article  CAS  PubMed  Google Scholar 

  12. Mysliwiec AG, Ornstein DL (2002) Matrix metalloproteinases in colorectal cancer. Clin Colorectal Cancer 1:208–219

    PubMed  Google Scholar 

  13. Murray GI, Duncan ME, O’Neil P, Melvin WT, Fothergill JE (1996) Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 2:461–462

    CAS  PubMed  Google Scholar 

  14. Zeng ZS, Huang Y, Cohen AM, Guillem JG (1996) Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. J Clin Oncol 14:3133–3140

    CAS  PubMed  Google Scholar 

  15. Adachi Y, Yamamoto H, Itoh F, Hinoda Y, Okada Y, Imai K (1999) Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers. Gut 45:252–258

    CAS  PubMed  Google Scholar 

  16. Kikuchi R, Noguchi T, Takeno S, Kubo N, Uchida Y (2000) Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma. Br J Cancer 83:215–218

    Article  CAS  PubMed  Google Scholar 

  17. Sardinha TC, Nogueras JJ, Xiong H, Weiss EG, Wexner SD, Abramson S (2000) Membrane-type 1 matrix metalloproteinase mRNA expression in colorectal cancer. Dis Colon Rectum 43:389–395

    CAS  PubMed  Google Scholar 

  18. Roeb E, Dietrich CG, Winograd R, Arndt M, Breuer B, Faß J, Schumpelick V, Matern S (2001) Activity and cellular origin of gelatinases in colon and rectal cancer: differential activity of MMP-9. Cancer 92:2680–2691

    Article  CAS  PubMed  Google Scholar 

  19. Leeman MF, McKay JA, Murray GI (2002) Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer. J Clin Pathol 55:758–762

    Article  CAS  PubMed  Google Scholar 

  20. Roeb E, Purucker E, Breuer B, Nguyen HN, Heinrich PC, Rose-John S, Matern S (1997) TIMP expression in toxic and cholestatic liver injury in rats. J Hepatol 27:535–544

    Article  CAS  Google Scholar 

  21. Yamashita K, Azumano I, Mai M, Okada Y (1998) Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implication for vessel invasion and metastasis. Int J Cancer 79:187–194

    Article  CAS  PubMed  Google Scholar 

  22. Masaki T, Matsuoka H, Sugiyama M, Abe N, Goto A, Sakamoto A, Atomi Y (2001) Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas. Br J Cancer 84:1317–1321

    Article  CAS  PubMed  Google Scholar 

  23. Yamamoto H, Itoh F, Hinoda Y, Senota A, Yoshimoto M, Nakamura H, Imai K, Yachi A (1994) Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin. Biochem Biophys Res Commun 201:657–664

    Article  CAS  PubMed  Google Scholar 

  24. Wilson CL, Matrisian LM (1996) Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 28:123–136

    Article  CAS  PubMed  Google Scholar 

  25. Crabbe T, Smith B, O’Connell J, Docherty A (1994) Human progelatinase A can be activated by matrilysin. FEBS Lett 345:14–16

    Article  CAS  PubMed  Google Scholar 

  26. Imai K, Yokohama Y, Nakanishi I, Ohuchi E, Fujii Y, Nakai N, Okada Y (1995) Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymatic properties. J Biol Chem 270:6691–6697

    Article  CAS  PubMed  Google Scholar 

  27. Witty JP, McDonnell S, Newell KJ, Cannon P, Navre M, Tressler RJ, Matrisian LM (1994) Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. Cancer Res 54:4805–4812

    CAS  PubMed  Google Scholar 

  28. Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH (1996) Expression of most matrix metalloproteinase family members in breast cancer represents a tumour-induced host response. Am J Pathol 149:273–282

    CAS  PubMed  Google Scholar 

  29. Airola K, Karonen T, Vaalamo M, Lehti K, Lohi J, Kariniemi AL, Keski-Oja J, Saarialho-Kere UK (1999) Expression of collagenases-1 and −3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Br J Cancer 80:733–743

    Article  PubMed  Google Scholar 

  30. Newell KJ, Witty JP, Rodgers WH, Matrisian LM (1994) Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol Carcinog 10:199–206

    CAS  PubMed  Google Scholar 

  31. Harris ED Jr, Krane SM (1974) Collagenases (second of three parts). N Engl J Med 291:605–609

    PubMed  Google Scholar 

  32. Shiozawa J, Ito M, Nakayama T, Nakashima M, Kohno S, Sekine I (2000) Expression of matrix metalloproteinase-1 in human colorectal carcinoma. Mod Pathol 13:925–933

    CAS  PubMed  Google Scholar 

  33. Sunami E, Tsuno N, Osada T, Saito S, Kitayama J, Tomozawa S, Tsuruo T, Shibata Y, Muto T, Nagawa H (2000) MMP-1 is a prognostic marker for hematogenous metastasis of colorectal cancer. Oncologist 5:108–114

    CAS  PubMed  Google Scholar 

  34. Nakopoulou L, Giannopoulou I, Gakiopoulou H, Liapis H, Tzonou A, Davaris PS (1999) Matrix metalloproteinase-1 and -3 in breast cancer: correlation with progesterone receptors and other clinicopathologic features. Hum Pathol 30:436–442

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Financial support was provided to E.R. by the Deutsche Forschungsgemeinschaft (RO 957/6-1), the Federal Ministry of Education and Research (BMBF Network of Competence in Medicine, Hep-Net), and the START project Prognosis Factors of Malignant Tumors, RWTH Aachen, Germany. The technical assistance of Mrs. M. Styrnik is gratefully acknowledged.

Author information

Authors and Affiliations

  1. Medical Clinic III, Rheinisch-Westfälische Technische Hochschule Aachen, Pauwelsstrasse 30, 52057, Aachen, Germany

    Elke Roeb, Marlies Arndt, Bettina Jansen & Siegfried Matern

  2. Department of Surgery, Rheinisch-Westfälische Technische Hochschule Aachen, Pauwelsstrasse 30, 52057, Aachen, Germany

    Volker Schumpelick

Authors
  1. Elke Roeb
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marlies Arndt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bettina Jansen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Volker Schumpelick
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Siegfried Matern
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elke Roeb.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roeb, E., Arndt, M., Jansen, B. et al. Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas. Int J Colorectal Dis 19, 518–524 (2004). https://doi.org/10.1007/s00384-004-0592-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-004-0592-6

Keywords

Search

Navigation